UGA Biopharma GmbH was established in 2009 in Hennigsdorf near Berlin, Germany. UGA Biopharma specializes in the development of monoclonal cell lines for the production of advanced biologics and biosimilars. Thanks to our technology platform and the expertise of our international team, we are able to deliver top-quality processes rapidly and at low cost. Moreover, our portfolio includes ready-to-use cell lines, which allow our customers to get started quickly in biosimilar development for their own production.
Our own products – with the optimally matched First CHOice® cell culture medium and First CHOice® feeds – offer a high-grade alternative to other commercially available media and feeds. They ensure excellent productivity of our cell lines, as well as high quality of the products.